Biocon
Soichi Murata is an experienced professional in the pharmaceutical and medical industries, currently serving as the Japan Country Head at Biocon since February 2024. Prior to this role, Soichi held positions as Country Head at Solara Active Pharma Sciences from July 2022 to February 2024 and as Senior Sales Marketing Manager at TAPI - Teva Active Pharmaceutical Ingredients from December 2018 to June 2022. Earlier career experiences include roles as Marketing Manager at PROTEA JAPAN and Abbott Medical Optics, Senior Marketing Manager at Jeisys Medical, and Product Marketing Manager at Lumenis. Soichi started in sales with Merck Group and Integral Corporation. Educational qualifications include an MBA from The University of Manchester and studies at McGill University - Desautels Faculty of Management.
This person is not in any teams
This person is not in any offices
Biocon
21 followers
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company's brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.